您的位置: 首页 > 农业专利 > 详情页

Phosphaplatin and its use in the treatment of cancer resistant to cisplatin and carboplatin
专利权人:
オハイオ ユニバーシティー
发明人:
ボース,ラシンドラ,エヌ.,ボース,ラシンドラ,エヌ.
申请号:
JP2010520294
公开号:
JP5385274B2
申请日:
2008.08.06
申请国别(地区):
JP
年份:
2014
代理人:
摘要:
The present invention provides phosphaplatins, stable isolated monomeric phosphato complexes of platinum (II) and (IV), and methods of use thereof for treating cancers, including cisplatin- and carboplatin-resistant cancers. Unlike cisplatin, these complexes do not readily undergo hydrolysis and are quite soluble and stable in aqueous solutions. Moreover, these complexes - unlike cisplatin, carboplatin, and related platinum-based anti-cancer agents - do not bind DNA. Rather, data suggests that phosphaplatins trigger overexpression of fas and fas-related transcription factors and some proapoptotic genes such as Bak and Bax. Nevertheless, the complexes exhibit tremendous cytotoxicity towards cancer cells. Thus, the present invention provides novel platinum anticancer agents that have a different molecular target than those in the art.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充